Over roughly the last week (≈8–15 June 2026), the most concrete vaccine developments have been: (1) further consolidation of adult pneumococcal and RSV strategies in Australia, (2) new Canadian COVID-19 guidance for...
Asia (including Southeast Asia, China, and India) India – CDSCO/SEC pauses Bharat Biotech MTBVAC Phase III authorisation (6 June 2026) India’s Subject Expert Committee identified data gaps and a serious adverse...